List view / Grid view

Articles

D is for Diabetes

17 November 2016 | By Niamh Louise Marriott, Digital Content Producer

D is for Diabetes - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research into Diabetes...

C is for CRISPR

16 November 2016 | By Niamh Louise Marriott, Digital Content Producer

C is for CRISPR - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research of CRISPR technology

B is for Biomarkers

15 November 2016 | By Niamh Louise Marriott, Digital Content Producer

B is for Biomarkers - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research on the subject of biomarkers.

A is for Alzheimer’s disease

14 November 2016 | By Niamh Louise Marriott, Digital Content Producer

A is for Alzheimer's - the first instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research on the fight against this deadly disease

IVF babies: Easy as 1, 2…3?

3 November 2016 | By Niamh Louise Marriott, Digital Content Producer

The ethics of three parent babies has been widely debated - should it be used to save children from deadly mitochondrial diseases or are scientists "playing God"? Here's everything you need to know to decide...

Rural, poor and sick: The unseen cancer crisis in America

20 October 2016 | By Aaron Yao, PhD, University of Virginia School of Medicine

PhD student Aaron Yao highlights the shocking disparities between rural and urban eastern America and how the odds of cancer survival do not favour the impoverished...

Drug Target Review – Issue #3 2016

20 September 2016 | By Drug Target Review

In Issue #3 2016: Flow Cytometry, Enzymes, Imaging, GPCRs, Hit-To-Lead, CNS, Companion Diagnostics, and much more...

Hit-To-Lead In-Depth Focus 2016

20 September 2016 | By Drug Target Review

In this Hit-To-Lead In-Depth Focus: Hit-to-lead in drug discovery; Zebrafish early-life stages as neurological screening and detection tools...